NDC product
Alpha CF
NDC 53499-9339 · Schwabe North America, Inc.
Key facts
| Product NDC | 53499-9339 |
|---|---|
| Proprietary name | Alpha CF |
| Nonproprietary name | ACONITUM NAPELLUS, BRYONIA ALBA ROOT, EUCALYPTUS GLOBULUS LEAF, EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT, IPECAC, PHOSPHORUS |
| Substances | ACONITUM NAPELLUS, BRYONIA ALBA ROOT, EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT, IPECAC, EUCALYPTUS GLOBULUS LEAF, PHOSPHORUS |
| Dosage form | TABLET |
| Route | SUBLINGUAL |
| Labeler | Schwabe North America, Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED HOMEOPATHIC |
| Marketing start | Apr 1, 2017 |
| Marketing end | Mar 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory